Browsing by Author "Wang, Ke"
Now showing items 1-8 of 8
-
Cocrystallisation of Daidzein with pyridine-derived molecules: Screening, structure determination and characterisation
Bolus, Linzie; Wang, Ke; Pask, Christopher; Lai, Xiaojun; Li, M. (Article)Daidzein (7,4' -dihydroxyisoflavone, DAI) is an isoflavone found in soybeans and Pueraria. DAI has potential therapeutic benefits on cancer and osteoporosis yet has quite low solubility, limiting its use. Herein a cocrystal ... -
In Vitro Dissolution Studies of Immediate Release and Extended Release Formulation using Flow-through Cell Apparatus 4. Dissolution technologies
The aims of this study were to evaluate the dissolution performance of solid dosage forms using the open and closed modes of the FTC Apparatus 4 under different flow rates and provide examples to demonstrate the advantages ... -
Insight into Flufenamic Acid Cocrystal Dissolution in the Presence of a Polymer in Solution: from Single Crystal to Powder Dissolution
Guo, Minshan; Wang, Ke; Qiao, Ning; Fabian, Laszlo; Sadiq, Ghazala; Li, M. (Article)Effects of three polymers, polyethylene glycol (PEG), polyvinylpyrrolidone (PVP), and copolymer of vinylpyrrolidone/vinyl acetate (PVP-VA), on the dissolution behavior of the cocrystals of flufenamic acid with theophylline ... -
Investigation of the Effect of Hydroxypropyl Methylcellulose on the Phase Transformation and Release Profiles of Carbamazepine-Nicotinamide Cocrystal
Li, M.; Qiu, Shi; Wang, Ke; Lai, Xiaojun; Rehan, Mohammad (Article)Purpose The aim of this work was to investigate the influence of hydroxypropyl methylcellulose (HPMC) on the phase transformation and release profile of carbamazepine-nicotinamide (CBZ-NIC) cocrystal in solution and in ... -
Understanding the effects of a polymer on the surface dissolution of pharmaceutical cocrystals using combined experimental and molecular dynamics simulation approaches
Li, M.; Kirubakaran, P.; Wang, Ke; Rosbottom, I.; Cross, R. B. M. (Article)The molecular interactions between the surfaces of cocrystals [i.e., flufenamic acid and theophylline (FFA-TP), flufenamic acid and nicotinamide (FFA-NIC), and carbamazepine and nicotinamide (CBZ-NIC)] and the polymers ...